Skip to main content
Log in

MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The properties of MDL 72222 (1αH,3α,5αH-tropan-3-yl-3,5-dichlorobenzoate), a novel compound with potent and selective blocking actions at certain excitatory 5-hydroxytryptamine (5-HT) receptors on mammalian peripheral neurones, are described.

On the rabbit isolated heart, MDL 72222 was a potent antagonist of responses mediated through the receptors for 5-HT present on the terminal sympathetic fibres. The threshold for antagonism was approximately 0.1 nM and the negative logarithm of the molar concentration of MDL 72222 which reduced the chronotropic response of the isolated rabbit heart to twice an ED50 of 5-HT to that of the ED50 was 9.27. MDL 72222 was also highly selective since responses to the nicotine receptor agonist, dimethylphenylpiperazinum iodine (DMPP), were inhibited only at concentrations more than 1000 times those necessary to inhibit 5-HT.

In the anaesthetised rat, MDL 72222 produced marked blockade of the Bezold-Jarisch effect of 5-HT. Again, inhibition was selective since much higher doses of MDL 72222 failed to alter the response to electrical stimulation of the efferent vagus nerves. In contrast, MDL 72222 proved only a weak and essentially non-selective antagonist of responses mediated by the 5-HT M-receptor present on the cholinergic nerves of the guinea-pig ileum.

MDL 72222 does not block smooth muscle contractile responses elicited by oxytocin or mediated through 5-HT D-receptors, muscarinic or nicotinic cholinoceptors or histamine H1-receptors except at relatively high concentrations. Similarly, in a number of radioligand binding assays carried out using brain tissue membranes, the displacing effects of MDL 72222 were absent or weak at sites identifying compounds with activity at α1, α2 or β-adrenoceptors, 5-HT1 or 5-HT2 receptors, benzodiazepine receptors or histamine H1-receptors.

MDL 72222 is the first reported selective and potent antagonist of responses mediated through the 5-HT receptors present on the terminal sympathetic neurones of the rabbit heart and on the neurones subserving the afferent limb of the Bezold-Jarisch reflex. The compound should provide a useful means by which responses mediated through such sites can be distinguished.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aghajanian GK (1981) The modulatory role of serotonin at multiple receptors in brain. In: Jacobs BL, Gelperin A (eds) Serotonin neurotransmission and behavior. The MIT Press, Cambridge, Massachussetts, pp 156–185

    Google Scholar 

  • Bülbring E, Wajda I (1945) Biological comparison of local anaesthetics. J Pharmacol Exp Ther 85:78–84

    Google Scholar 

  • Day MD, Vane JR (1963) An analysis of the direct and indirect actions of drugs on the isolated guinea-pig ileum. Br J Pharmacol 20:150–170

    Google Scholar 

  • Fozard JR (1979) Blockade of receptors for 5-hydroxytryptamine on the sympathetic nerves of the rabbit heart. In: Langer SZ, Starke K, Dubocovich ML (eds) Advances in the biosciences. Pergamon, Oxford, pp 327–332

    Google Scholar 

  • Fozard JR (1982) Basic mechanisms of antimigraine drugs. In: Critchley M, Friedman AP, Gorini S, Sicuteri F (eds) Advances in neurology, vol 33, Headache: physiopathological and clinical concepts. Raven Press, New York, pp 295–307

    Google Scholar 

  • Fozard JR (1983a) MDL 72222: A potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Br J Pharmacol 80:466P

    Google Scholar 

  • Fozard JR (1983b) Differences between receptors for 5-hydroxytryptamine on autonomic neurones revealed by nor-(−)-cocaine. J Auton Pharmacol 3:21–26

    Google Scholar 

  • Fozard JR, Gittos MW (1983) Selective blockade of 5-hydroxytryptamine neuronal receptors by benzoic acid esters of tropine. Br J Pharmacol 80:511P

  • Fozard JR, Host M (1982) Selective inhibition of the Bezold-Jarisch effect of 5-HT in the rat by antagonists at neuronal 5-HT receptors. Br J Pharmacol 77:520P

    Google Scholar 

  • Fozard JR, Leach GDH (1968) The hypotensive action of 5-hydroxytryptamine (5-HT) in anaesthetized and pithed rats. Eur J Pharmacol 2:239–249

    Google Scholar 

  • Fozard JR, Mobarok Ali ATM (1978a) Blockade of neuronal tryptamine receptors by metoclopramide. Eur J Pharmacol 49:109–112

    Google Scholar 

  • Fozard JR, Mobarok Ali ATM (1978b) Receptors for 5-hydroxytryptamine on the sympathetic nerves of the rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 301:223–235

    Google Scholar 

  • Fozard JR, Muscholl E (1971) A useful muscarinic parameter and the differential recording of atrial and ventricular tension in the perfused rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 270:319–325

    Google Scholar 

  • Fozard JR, Mwaluko GMP (1976) Mechanism of the indirect sympathomimetic effect of 5-hydroxytryptamine on the isolated heart of the rabbit. Br J Pharmacol 57:115–125

    Google Scholar 

  • Fozard JR, Mobarok Ali ATM, Newgrosh G (1979) Blockade of serotonin receptors on autonomic neurones by (−)-cocaine and some related compounds. Eur J Pharmacol 59:195–210

    Google Scholar 

  • Gaddum JH, Picarelli ZP (1957) Two kinds of tryptamine receptor. Br J Pharmacol Chemother 12:323–328

    Google Scholar 

  • Gerschenfeld HM, Paupardin-Tritsch D, Deterre D (1981) Neuronal responses to serotonin: A second view. In: Jacobs BL, Gelperin A (eds) Serotonin neurotransmission and behavior. The MIT Press, Cambridge, Massachussetts, pp 105–130

    Google Scholar 

  • Giachetti A, Hammer R, Montagna E (1982) Muscarinic receptor subtypes and responses to McN A-343 and pirenzepine. Br J Pharmacol 77:428P

  • Göthert M, Dührsen V (1979) Effects of 5-hydroxytryptamine and related compounds on the sympathetic nerves of the rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 308:9–18

    Google Scholar 

  • Haefely W (1972) Electrophysiology of the adrenergic neurone. In: Blaschko H, Muscholl E (ed) Handbook of experimental pharmacology, vol 23, Catecholamines. Springer, Berlin Heidelberg New York, pp 661–725

    Google Scholar 

  • Haefely W (1974a) Muscarinic postsynaptic events in the cat superior cervical ganglion in situ. Naunyn-Schmiedeberg's Arch Pharmacol 281:119–143

    Google Scholar 

  • Haefely W (1974b) The effects of 5-hydroxytryptamine and some related compounds on the cat superior cervical ganglion in situ. Naunyn-Schmiedeberg's Arch Pharmacol 281:145–165

    Google Scholar 

  • Jacob J, Poite-Bevièrre M (1960) Actions de la sérotonine et de la benzyl-1-diméthyl-2,5-sérotonine sur le coeur isolé de lapin. Arch Int Pharmacodyn Ther 127:11–26

    Google Scholar 

  • Krayer O (1961) The history of the Bezold-Jarisch effect. Naunyn-Schmiedebergs Arch Pharmacol 240:361–368

    Google Scholar 

  • Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenbeck J, Janssen PAJ (1981) Receptor binding profile of R41468 a novel antagonist at 5-HT2 receptors. Life Sci 28:1115–1122

    Google Scholar 

  • Paintal AS (1973) Vagal sensory receptors and their reflex effects. Physiol Rev 53:159–227

    Google Scholar 

  • Salmoiraghi GC, Page IH, McGubbin JW (1956) Cardiovascular and respiratory response to intravenous serotonin in rats. J Pharmacol Exp Ther 118:477–481

    Google Scholar 

  • Schild HO (1947) pA, a new scale for the measurement of drug antagonism. Br J Pharmacol 2:189–206

    Google Scholar 

  • Shipley RE, Tilden JH (1947) A pithed rat preparation suitable for assaying presor substances. Proc Soc Exp Biol Med 64:453–455

    Google Scholar 

  • Spedding M (1982) Assessment of “Ca2+-antagonist” effects of drugs in K+-depolarized smooth muscle: differentiation of antagonist subgroups. Naunyn-Schmiedeberg's Arch Pharmacol 318:234–240

    Google Scholar 

  • University of Edinburgh Staff (1970) Pharmacological experiments on isolated preparations. Livingstone, Edinburgh London

    Google Scholar 

  • Wallis DI (1979) The apparent multiplicity of ganglionic receptors. In: Kalsner (ed) Trends in autonomic pharmacology, vol 1. Urban and Schwarzenberg, Baltimore, pp 21–57

    Google Scholar 

  • Wallis D (1981) Neuronal 5-hydroxytryptamine receptors outside the central nervous system. Life Sci 29:2345–2355

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fozard, J.R. MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 326, 36–44 (1984). https://doi.org/10.1007/BF00518776

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00518776

Key words

Navigation